Eupraxia Pharmaceuticals Stock News & Updates

[WKN: A3EGRS]

Eupraxia Pharmaceuticals

Eupraxia Pharmaceuticals: How Targeted Drug Release Addresses Billion-Dollar Markets – Oppenheimer Sees Massive Price Potential

07/24/2025 at 04 PM

Eupraxia Pharmaceuticals Inc. (EPRX): Cantor Fitzgerald Sees 108% Price Potential!

Currently, Eupraxia Pharmaceuticals Inc. (EPRX) is standing out positively. The biotech company specializes...

07/24/2025 at 01 PM

Analysts' Top 5 Price Targets of July 24, 2025

AxoGen Inc. [US05463X1063] Lake Street reaffirms Buy rating with a price target of $30 (123% upside...

‹
1
›